Home > > > Report Detail

Global Human Microbiome Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Publisher Name :
Date: 14-Oct-2021
No. of pages: 101

The Human Microbiome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Human Microbiome size is estimated to be USD 692.1 million in 2026 from USD 325.4 million in 2020, with a change XX% between 2020 and 2021. The global Human Microbiome market size is expected to grow at a CAGR of 20.8% for the next five years.

Market segmentation

Human Microbiome market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- Gastrointestinal Tract Human Micobiome

- Urogenital Tract Human Micobiome

- Others

Market segment by Application, can be divided into

- Treatment

- Diagnosis

Market segment by players, this report covers

- Vedanta

- Seres Therapeutics

- Second Genome

- Rebiotix

- ActoGeniX

- Enterome BioScience

- AvidBiotics

- 4D Pharma Research Ltd

- Enterologics

- Metabogen

- Metabiomics

- Ritter Pharmaceuticals

- Osel

- Symberix

- Miomics

- Symbiotix Biotherapies

- MicroBiome Therapeutics LLC

Market segment by regions, regional analysis covers

- North America (United States, Canada, and Mexico)

- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

- South America (Brazil, Argentina, Rest of South America)

- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Human Microbiome product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Human Microbiome, with revenue, gross margin and global market share of Human Microbiome from 2019 to 2021.

Chapter 3, the Human Microbiome competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Human Microbiome market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Human Microbiome research findings and conclusion, appendix and data source.

Global Human Microbiome Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Human Microbiome
1.2 Classification of Human Microbiome by Type
1.2.1 Overview: Global Human Microbiome Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Human Microbiome Revenue Market Share by Type in 2020
1.2.3 Gastrointestinal Tract Human Micobiome
1.2.4 Urogenital Tract Human Micobiome
1.2.5 Others
1.3 Global Human Microbiome Market by Application
1.3.1 Overview: Global Human Microbiome Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Treatment
1.3.3 Diagnosis
1.4 Global Human Microbiome Market Size & Forecast
1.5 Global Human Microbiome Market Size and Forecast by Region
1.5.1 Global Human Microbiome Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Human Microbiome Market Size by Region, (2016-2021)
1.5.3 North America Human Microbiome Market Size and Prospect (2016-2026)
1.5.4 Europe Human Microbiome Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Human Microbiome Market Size and Prospect (2016-2026)
1.5.6 South America Human Microbiome Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Human Microbiome Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Microbiome Market Drivers
1.6.2 Human Microbiome Market Restraints
1.6.3 Human Microbiome Trends Analysis
2 Company Profiles
2.1 Vedanta
2.1.1 Vedanta Details
2.1.2 Vedanta Major Business
2.1.3 Vedanta Human Microbiome Product and Solutions
2.1.4 Vedanta Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Vedanta Recent Developments and Future Plans
2.2 Seres Therapeutics
2.2.1 Seres Therapeutics Details
2.2.2 Seres Therapeutics Major Business
2.2.3 Seres Therapeutics Human Microbiome Product and Solutions
2.2.4 Seres Therapeutics Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Seres Therapeutics Recent Developments and Future Plans
2.3 Second Genome
2.3.1 Second Genome Details
2.3.2 Second Genome Major Business
2.3.3 Second Genome Human Microbiome Product and Solutions
2.3.4 Second Genome Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Second Genome Recent Developments and Future Plans
2.4 Rebiotix
2.4.1 Rebiotix Details
2.4.2 Rebiotix Major Business
2.4.3 Rebiotix Human Microbiome Product and Solutions
2.4.4 Rebiotix Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Rebiotix Recent Developments and Future Plans
2.5 ActoGeniX
2.5.1 ActoGeniX Details
2.5.2 ActoGeniX Major Business
2.5.3 ActoGeniX Human Microbiome Product and Solutions
2.5.4 ActoGeniX Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 ActoGeniX Recent Developments and Future Plans
2.6 Enterome BioScience
2.6.1 Enterome BioScience Details
2.6.2 Enterome BioScience Major Business
2.6.3 Enterome BioScience Human Microbiome Product and Solutions
2.6.4 Enterome BioScience Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Enterome BioScience Recent Developments and Future Plans
2.7 AvidBiotics
2.7.1 AvidBiotics Details
2.7.2 AvidBiotics Major Business
2.7.3 AvidBiotics Human Microbiome Product and Solutions
2.7.4 AvidBiotics Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 AvidBiotics Recent Developments and Future Plans
2.8 4D Pharma Research Ltd
2.8.1 4D Pharma Research Ltd Details
2.8.2 4D Pharma Research Ltd Major Business
2.8.3 4D Pharma Research Ltd Human Microbiome Product and Solutions
2.8.4 4D Pharma Research Ltd Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 4D Pharma Research Ltd Recent Developments and Future Plans
2.9 Enterologics
2.9.1 Enterologics Details
2.9.2 Enterologics Major Business
2.9.3 Enterologics Human Microbiome Product and Solutions
2.9.4 Enterologics Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Enterologics Recent Developments and Future Plans
2.10 Metabogen
2.10.1 Metabogen Details
2.10.2 Metabogen Major Business
2.10.3 Metabogen Human Microbiome Product and Solutions
2.10.4 Metabogen Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Metabogen Recent Developments and Future Plans
2.11 Metabiomics
2.11.1 Metabiomics Details
2.11.2 Metabiomics Major Business
2.11.3 Metabiomics Human Microbiome Product and Solutions
2.11.4 Metabiomics Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Metabiomics Recent Developments and Future Plans
2.12 Ritter Pharmaceuticals
2.12.1 Ritter Pharmaceuticals Details
2.12.2 Ritter Pharmaceuticals Major Business
2.12.3 Ritter Pharmaceuticals Human Microbiome Product and Solutions
2.12.4 Ritter Pharmaceuticals Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Ritter Pharmaceuticals Recent Developments and Future Plans
2.13 Osel
2.13.1 Osel Details
2.13.2 Osel Major Business
2.13.3 Osel Human Microbiome Product and Solutions
2.13.4 Osel Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Osel Recent Developments and Future Plans
2.14 Symberix
2.14.1 Symberix Details
2.14.2 Symberix Major Business
2.14.3 Symberix Human Microbiome Product and Solutions
2.14.4 Symberix Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Symberix Recent Developments and Future Plans
2.15 Miomics
2.15.1 Miomics Details
2.15.2 Miomics Major Business
2.15.3 Miomics Human Microbiome Product and Solutions
2.15.4 Miomics Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Miomics Recent Developments and Future Plans
2.16 Symbiotix Biotherapies
2.16.1 Symbiotix Biotherapies Details
2.16.2 Symbiotix Biotherapies Major Business
2.16.3 Symbiotix Biotherapies Human Microbiome Product and Solutions
2.16.4 Symbiotix Biotherapies Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Symbiotix Biotherapies Recent Developments and Future Plans
2.17 MicroBiome Therapeutics LLC
2.17.1 MicroBiome Therapeutics LLC Details
2.17.2 MicroBiome Therapeutics LLC Major Business
2.17.3 MicroBiome Therapeutics LLC Human Microbiome Product and Solutions
2.17.4 MicroBiome Therapeutics LLC Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 MicroBiome Therapeutics LLC Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Human Microbiome Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Human Microbiome Players Market Share
3.2.2 Top 10 Human Microbiome Players Market Share
3.2.3 Market Competition Trend
3.3 Human Microbiome Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Human Microbiome Revenue and Market Share by Type (2016-2021)
4.2 Global Human Microbiome Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Human Microbiome Revenue Market Share by Application (2016-2021)
5.2 Human Microbiome Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Human Microbiome Revenue by Type (2016-2026)
6.2 North America Human Microbiome Revenue by Application (2016-2026)
6.3 North America Human Microbiome Market Size by Country
6.3.1 North America Human Microbiome Revenue by Country (2016-2026)
6.3.2 United States Human Microbiome Market Size and Forecast (2016-2026)
6.3.3 Canada Human Microbiome Market Size and Forecast (2016-2026)
6.3.4 Mexico Human Microbiome Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Human Microbiome Revenue by Type (2016-2026)
7.2 Europe Human Microbiome Revenue by Application (2016-2026)
7.3 Europe Human Microbiome Market Size by Country
7.3.1 Europe Human Microbiome Revenue by Country (2016-2026)
7.3.2 Germany Human Microbiome Market Size and Forecast (2016-2026)
7.3.3 France Human Microbiome Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Human Microbiome Market Size and Forecast (2016-2026)
7.3.5 Russia Human Microbiome Market Size and Forecast (2016-2026)
7.3.6 Italy Human Microbiome Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Human Microbiome Revenue by Type (2016-2026)
8.2 Asia-Pacific Human Microbiome Revenue by Application (2016-2026)
8.3 Asia-Pacific Human Microbiome Market Size by Region
8.3.1 Asia-Pacific Human Microbiome Revenue by Region (2016-2026)
8.3.2 China Human Microbiome Market Size and Forecast (2016-2026)
8.3.3 Japan Human Microbiome Market Size and Forecast (2016-2026)
8.3.4 South Korea Human Microbiome Market Size and Forecast (2016-2026)
8.3.5 India Human Microbiome Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Human Microbiome Market Size and Forecast (2016-2026)
8.3.7 Australia Human Microbiome Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Human Microbiome Revenue by Type (2016-2026)
9.2 South America Human Microbiome Revenue by Application (2016-2026)
9.3 South America Human Microbiome Market Size by Country
9.3.1 South America Human Microbiome Revenue by Country (2016-2026)
9.3.2 Brazil Human Microbiome Market Size and Forecast (2016-2026)
9.3.3 Argentina Human Microbiome Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Human Microbiome Revenue by Type (2016-2026)
10.2 Middle East & Africa Human Microbiome Revenue by Application (2016-2026)
10.3 Middle East & Africa Human Microbiome Market Size by Country
10.3.1 Middle East & Africa Human Microbiome Revenue by Country (2016-2026)
10.3.2 Turkey Human Microbiome Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Human Microbiome Market Size and Forecast (2016-2026)
10.3.4 UAE Human Microbiome Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Human Microbiome Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Human Microbiome Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Human Microbiome Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Human Microbiome Revenue (USD Million) by Region (2016-2021)
Table 5. Global Human Microbiome Revenue Market Share by Region (2021-2026)
Table 6. Vedanta Corporate Information, Head Office, and Major Competitors
Table 7. Vedanta Major Business
Table 8. Vedanta Human Microbiome Product and Solutions
Table 9. Vedanta Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Seres Therapeutics Corporate Information, Head Office, and Major Competitors
Table 11. Seres Therapeutics Major Business
Table 12. Seres Therapeutics Human Microbiome Product and Solutions
Table 13. Seres Therapeutics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Second Genome Corporate Information, Head Office, and Major Competitors
Table 15. Second Genome Major Business
Table 16. Second Genome Human Microbiome Product and Solutions
Table 17. Second Genome Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Rebiotix Corporate Information, Head Office, and Major Competitors
Table 19. Rebiotix Major Business
Table 20. Rebiotix Human Microbiome Product and Solutions
Table 21. Rebiotix Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. ActoGeniX Corporate Information, Head Office, and Major Competitors
Table 23. ActoGeniX Major Business
Table 24. ActoGeniX Human Microbiome Product and Solutions
Table 25. ActoGeniX Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Enterome BioScience Corporate Information, Head Office, and Major Competitors
Table 27. Enterome BioScience Major Business
Table 28. Enterome BioScience Human Microbiome Product and Solutions
Table 29. Enterome BioScience Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. AvidBiotics Corporate Information, Head Office, and Major Competitors
Table 31. AvidBiotics Major Business
Table 32. AvidBiotics Human Microbiome Product and Solutions
Table 33. AvidBiotics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. 4D Pharma Research Ltd Corporate Information, Head Office, and Major Competitors
Table 35. 4D Pharma Research Ltd Major Business
Table 36. 4D Pharma Research Ltd Human Microbiome Product and Solutions
Table 37. 4D Pharma Research Ltd Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Enterologics Corporate Information, Head Office, and Major Competitors
Table 39. Enterologics Major Business
Table 40. Enterologics Human Microbiome Product and Solutions
Table 41. Enterologics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Metabogen Corporate Information, Head Office, and Major Competitors
Table 43. Metabogen Major Business
Table 44. Metabogen Human Microbiome Product and Solutions
Table 45. Metabogen Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Metabiomics Corporate Information, Head Office, and Major Competitors
Table 47. Metabiomics Major Business
Table 48. Metabiomics Human Microbiome Product and Solutions
Table 49. Metabiomics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Ritter Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 51. Ritter Pharmaceuticals Major Business
Table 52. Ritter Pharmaceuticals Human Microbiome Product and Solutions
Table 53. Ritter Pharmaceuticals Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Osel Corporate Information, Head Office, and Major Competitors
Table 55. Osel Major Business
Table 56. Osel Human Microbiome Product and Solutions
Table 57. Osel Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Symberix Corporate Information, Head Office, and Major Competitors
Table 59. Symberix Major Business
Table 60. Symberix Human Microbiome Product and Solutions
Table 61. Symberix Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Miomics Corporate Information, Head Office, and Major Competitors
Table 63. Miomics Major Business
Table 64. Miomics Human Microbiome Product and Solutions
Table 65. Miomics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Symbiotix Biotherapies Corporate Information, Head Office, and Major Competitors
Table 67. Symbiotix Biotherapies Major Business
Table 68. Symbiotix Biotherapies Human Microbiome Product and Solutions
Table 69. Symbiotix Biotherapies Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. MicroBiome Therapeutics LLC Corporate Information, Head Office, and Major Competitors
Table 71. MicroBiome Therapeutics LLC Major Business
Table 72. MicroBiome Therapeutics LLC Human Microbiome Product and Solutions
Table 73. MicroBiome Therapeutics LLC Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Global Human Microbiome Revenue (USD Million) by Players (2019-2021)
Table 75. Global Human Microbiome Revenue Share by Players (2019-2021)
Table 76. Breakdown of Human Microbiome by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Human Microbiome Players Head Office, Products and Services Provided
Table 78. Human Microbiome Mergers & Acquisitions in the Past Five Years
Table 79. Human Microbiome New Entrants and Expansion Plans
Table 80. Global Human Microbiome Revenue (USD Million) by Type (2016-2021)
Table 81. Global Human Microbiome Revenue Share by Type (2016-2021)
Table 82. Global Human Microbiome Revenue Forecast by Type (2021-2026)
Table 83. Global Human Microbiome Revenue by Application (2016-2021)
Table 84. Global Human Microbiome Revenue Forecast by Application (2021-2026)
Table 85. North America Human Microbiome Revenue by Type (2016-2021) & (USD Million)
Table 86. North America Human Microbiome Revenue by Type (2021-2026) & (USD Million)
Table 87. North America Human Microbiome Revenue by Application (2016-2021) & (USD Million)
Table 88. North America Human Microbiome Revenue by Application (2021-2026) & (USD Million)
Table 89. North America Human Microbiome Revenue by Country (2016-2021) & (USD Million)
Table 90. North America Human Microbiome Revenue by Country (2021-2026) & (USD Million)
Table 91. Europe Human Microbiome Revenue by Type (2016-2021) & (USD Million)
Table 92. Europe Human Microbiome Revenue by Type (2021-2026) & (USD Million)
Table 93. Europe Human Microbiome Revenue by Application (2016-2021) & (USD Million)
Table 94. Europe Human Microbiome Revenue by Application (2021-2026) & (USD Million)
Table 95. Europe Human Microbiome Revenue by Country (2016-2021) & (USD Million)
Table 96. Europe Human Microbiome Revenue by Country (2021-2026) & (USD Million)
Table 97. Asia-Pacific Human Microbiome Revenue by Type (2016-2021) & (USD Million)
Table 98. Asia-Pacific Human Microbiome Revenue by Type (2021-2026) & (USD Million)
Table 99. Asia-Pacific Human Microbiome Revenue by Application (2016-2021) & (USD Million)
Table 100. Asia-Pacific Human Microbiome Revenue by Application (2021-2026) & (USD Million)
Table 101. Asia-Pacific Human Microbiome Revenue by Region (2016-2021) & (USD Million)
Table 102. Asia-Pacific Human Microbiome Revenue by Region (2021-2026) & (USD Million)
Table 103. South America Human Microbiome Revenue by Type (2016-2021) & (USD Million)
Table 104. South America Human Microbiome Revenue by Type (2021-2026) & (USD Million)
Table 105. South America Human Microbiome Revenue by Application (2016-2021) & (USD Million)
Table 106. South America Human Microbiome Revenue by Application (2021-2026) & (USD Million)
Table 107. South America Human Microbiome Revenue by Country (2016-2021) & (USD Million)
Table 108. South America Human Microbiome Revenue by Country (2021-2026) & (USD Million)
Table 109. Middle East & Africa Human Microbiome Revenue by Type (2016-2021) & (USD Million)
Table 110. Middle East & Africa Human Microbiome Revenue by Type (2021-2026) & (USD Million)
Table 111. Middle East & Africa Human Microbiome Revenue by Application (2016-2021) & (USD Million)
Table 112. Middle East & Africa Human Microbiome Revenue by Application (2021-2026) & (USD Million)
Table 113. Middle East & Africa Human Microbiome Revenue by Country (2016-2021) & (USD Million)
Table 114. Middle East & Africa Human Microbiome Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Human Microbiome Picture
Figure 2. Global Human Microbiome Revenue Market Share by Type in 2020
Figure 3. Gastrointestinal Tract Human Micobiome
Figure 4. Urogenital Tract Human Micobiome
Figure 5. Others
Figure 6. Human Microbiome Revenue Market Share by Application in 2020
Figure 7. Treatment Picture
Figure 8. Diagnosis Picture
Figure 9. Global Human Microbiome Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Human Microbiome Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Human Microbiome Revenue Market Share by Region (2016-2026)
Figure 12. Global Human Microbiome Revenue Market Share by Region in 2020
Figure 13. North America Human Microbiome Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Human Microbiome Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Human Microbiome Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Human Microbiome Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Human Microbiome Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Human Microbiome Market Drivers
Figure 19. Human Microbiome Market Restraints
Figure 20. Human Microbiome Market Trends
Figure 21. Vedanta Recent Developments and Future Plans
Figure 22. Seres Therapeutics Recent Developments and Future Plans
Figure 23. Second Genome Recent Developments and Future Plans
Figure 24. Rebiotix Recent Developments and Future Plans
Figure 25. ActoGeniX Recent Developments and Future Plans
Figure 26. Enterome BioScience Recent Developments and Future Plans
Figure 27. AvidBiotics Recent Developments and Future Plans
Figure 28. 4D Pharma Research Ltd Recent Developments and Future Plans
Figure 29. Enterologics Recent Developments and Future Plans
Figure 30. Metabogen Recent Developments and Future Plans
Figure 31. Metabiomics Recent Developments and Future Plans
Figure 32. Ritter Pharmaceuticals Recent Developments and Future Plans
Figure 33. Osel Recent Developments and Future Plans
Figure 34. Symberix Recent Developments and Future Plans
Figure 35. Miomics Recent Developments and Future Plans
Figure 36. Symbiotix Biotherapies Recent Developments and Future Plans
Figure 37. MicroBiome Therapeutics LLC Recent Developments and Future Plans
Figure 38. Global Human Microbiome Revenue Share by Players in 2020
Figure 39. Human Microbiome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players Human Microbiome Revenue Market Share in 2020
Figure 41. Global Top 10 Players Human Microbiome Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global Human Microbiome Revenue Share by Type in 2020
Figure 44. Global Human Microbiome Market Share Forecast by Type (2021-2026)
Figure 45. Global Human Microbiome Revenue Share by Application in 2020
Figure 46. Global Human Microbiome Market Share Forecast by Application (2021-2026)
Figure 47. North America Human Microbiome Sales Market Share by Type (2016-2026)
Figure 48. North America Human Microbiome Sales Market Share by Application (2016-2026)
Figure 49. North America Human Microbiome Revenue Market Share by Country (2016-2026)
Figure 50. United States Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe Human Microbiome Sales Market Share by Type (2016-2026)
Figure 54. Europe Human Microbiome Sales Market Share by Application (2016-2026)
Figure 55. Europe Human Microbiome Revenue Market Share by Country (2016-2026)
Figure 56. Germany Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific Human Microbiome Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific Human Microbiome Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Human Microbiome Revenue Market Share by Region (2016-2026)
Figure 64. China Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Human Microbiome Sales Market Share by Type (2016-2026)
Figure 71. South America Human Microbiome Sales Market Share by Application (2016-2026)
Figure 72. South America Human Microbiome Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa Human Microbiome Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa Human Microbiome Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa Human Microbiome Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE Human Microbiome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
  • Global Cytokine Inhibitor Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Cytokine Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The development prospects of cytokine inhibitors are very broad, and these drugs have many medical applications and researches. Cytokine inhibitors can reduce The activity of cytokines, thereby inhibiting their role in immune responses and reducing The activation of immune cells and The occurrence o......
  • Global Microbial Growth Media Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Microbial Growth Media is a nutrient component required by microorganisms, containing a variety of trace elements and trace elements, such as copper, iron, zinc, cobalt, manganese, etc. The global Microbial Growth Media market was valued at US$ 8007 million in 2023 and is anticipated to reach US$ 11530 million by 2030, witnessing a CAGR of 5.3% during The forecast period 2024-2030. The market for microbial growth media is essential in microbiology and biotechnology rese......
  • Global Protein Biochip Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92
    Protein Biochip is a small Protein array used to quickly detect a large number of unknown proteins. It works in a similar way to a DNA chip. First, a large number of known proteins (such as monoclonal antibodies) are placed on a small substrate and then exposed to and reacted with The unknown protein sample. Due to The specific binding between The antigen and The antibody, it can finally be detected by means of laser. The global Protein Biochip market was valued at US$ 145 million i......
  • Global Isothermal Nucleic Acid Amplification Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 103
    Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology. And in this report, we get The statistics on reagents used in isothermal nucleic acid amplification technology. Nucleic acid isothermal amplification is a newer technique that amplifies DNA or RNA specific fragment from few copies to billion-fold copies under a one temperature condition, unlike PCR amplification that needs at least 30-35 thermal cycles to accomplish The reaction. T......
  • Global Microfluidics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Microfluidics market size was valued at US$ 3118.7 million in 2023. With growing demand in downstream market, the Microfluidics is forecast to a readjusted size of US$ 7707.1 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Microfluidics market. Microfluidics are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 122
    According to our LPI (LP Information) latest study, the global Isothermal Nucleic Acid Amplification Technology (INAAT) market size was valued at US$ 6141.3 million in 2023. With growing demand in downstream market, the Isothermal Nucleic Acid Amplification Technology (INAAT) is forecast to a readjusted size of US$ 11250 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Isothermal Nucleic Acid Amplification Technol......
  • Global Cytokines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Cytokines market size was valued at US$ 203730 million in 2023. With growing demand in downstream market, the Cytokines is forecast to a readjusted size of US$ 611910 million by 2030 with a CAGR of 17.0% during review period. The research report highlights the growth potential of the global Cytokines market. Cytokines are expected to show stable growth in the future market. However, product differentiation, reducing costs, an......
  • Global Western Blot Imagers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Western Blot Imagers market size was valued at US$ 406 million in 2023. With growing demand in downstream market, the Western Blot Imagers is forecast to a readjusted size of US$ 578.4 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global Western Blot Imagers market. Western Blot Imagers are expected to show stable growth in the future market. However, prod......
  • Global Procalcitonin Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global Procalcitonin Antibody market size was valued at US$ million in 2023. With growing demand in downstream market, the Procalcitonin Antibody is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Procalcitonin Antibody market. Procalcitonin Antibody are expected to show stable growth in the future market. However, product di......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs